C. Keller

1.2k total citations
34 papers, 862 citations indexed

About

C. Keller is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, C. Keller has authored 34 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 9 papers in Cardiology and Cardiovascular Medicine and 8 papers in Molecular Biology. Recurrent topics in C. Keller's work include Lipoproteins and Cardiovascular Health (15 papers), Cancer, Lipids, and Metabolism (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). C. Keller is often cited by papers focused on Lipoproteins and Cardiovascular Health (15 papers), Cancer, Lipids, and Metabolism (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). C. Keller collaborates with scholars based in Germany, United States and United Kingdom. C. Keller's co-authors include G. Wolfram, H. Schuster, Keith A.A. Fox, James H. Chesebro, D A Chamberlain, Iwona Wieczorek, Marc Cohen, Janet Strain, Philip C. Adams and G. Parry and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and JNCI Journal of the National Cancer Institute.

In The Last Decade

C. Keller

33 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Keller Germany 14 467 406 182 141 132 34 862
Corinna Böttiger Germany 13 248 0.5× 310 0.8× 61 0.3× 93 0.7× 47 0.4× 16 691
H. J. Rupprecht Germany 13 216 0.5× 407 1.0× 39 0.2× 152 1.1× 58 0.4× 27 754
Kenzo Sugi Japan 5 188 0.4× 330 0.8× 33 0.2× 131 0.9× 42 0.3× 13 778
Marcel J. van den Brand Netherlands 10 713 1.5× 1.0k 2.5× 43 0.2× 102 0.7× 117 0.9× 12 1.5k
C N Chesterman Australia 15 129 0.3× 130 0.3× 38 0.2× 114 0.8× 83 0.6× 32 775
CJ Carter Canada 10 211 0.5× 261 0.6× 36 0.2× 57 0.4× 274 2.1× 21 851
Makoto Sugihara Japan 17 182 0.4× 208 0.5× 60 0.3× 131 0.9× 13 0.1× 92 785
Sebastián F. Ameriso United States 4 235 0.5× 577 1.4× 27 0.1× 35 0.2× 212 1.6× 4 748
Kousuke Kumeda Japan 13 135 0.3× 331 0.8× 38 0.2× 58 0.4× 192 1.5× 21 758
Magdalena Celińska‐Löwenhoff Poland 14 170 0.4× 125 0.3× 45 0.2× 42 0.3× 113 0.9× 32 605

Countries citing papers authored by C. Keller

Since Specialization
Citations

This map shows the geographic impact of C. Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Keller more than expected).

Fields of papers citing papers by C. Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Keller. The network helps show where C. Keller may publish in the future.

Co-authorship network of co-authors of C. Keller

This figure shows the co-authorship network connecting the top 25 collaborators of C. Keller. A scholar is included among the top collaborators of C. Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Keller. C. Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vogt, Anja, et al.. (2014). Zwei Formen familiärer Hypercholesterinämie: Unterschiede bei kardiovaskulären Risikofaktoren sowie kardialer und extrakardialer Atherosklerose. DMW - Deutsche Medizinische Wochenschrift. 139(50). 2573–2577. 2 indexed citations
2.
Hildebrandt, York, Yan Cao, C. Keller, et al.. (2012). Role of Interleukin 16 in Multiple Myeloma. JNCI Journal of the National Cancer Institute. 104(13). 1005–1020. 38 indexed citations
3.
Schilling, Richard J., Werner Kleophas, Hubert Messner, et al.. (2003). Efficacy and safety of DALI LDL‐apheresis at high blood flow rates: A prospective multicenter study. Journal of Clinical Apheresis. 18(4). 157–166. 12 indexed citations
4.
Bosch, Thomas, B. Schmidt, Edwin Fink, et al.. (2000). DALI Apheresis in Hyperlipidemic Patients: Biocompatibility, Efficacy, and Selectivity of Direct Adsorption of Lipoproteins from Whole Blood. Artificial Organs. 24(2). 81–90. 49 indexed citations
9.
Schuster, H., Philipp Ostwald, Pierre‐Frédéric Keller, G. Wolfram, & C. Keller. (1993). Identification of the serine-156 to leucine mutation in the low-density lipoprotein receptor in a German family with familial hypercholesterolemia. Journal of Molecular Medicine. 71(2). 172–5. 6 indexed citations
11.
Rauh, G, C. Keller, F. A. Spengel, et al.. (1992). Familial defective apolipoprotein B100: clinical characteristics of 54 cases. Atherosclerosis. 92(2-3). 233–241. 32 indexed citations
12.
Schuster, H., Steve E. Humphries, G Rauh, & C. Keller. (1992). First international workshop on familial defective apo B-100. Journal of Molecular Medicine. 70(10). 961–4. 3 indexed citations
13.
Rauh, G, et al.. (1992). Familial defective apolipoprotein B-100: a common cause of primary hypercholesterolemia. Journal of Molecular Medicine. 70(1). 77–84. 30 indexed citations
14.
Fischer, Harald, H. Schuster, C. Keller, G. Wolfram, & N. Zöllner. (1991). Identification of a 76-year-old patient with compound heterozygous Familial Hypercholesterolemia by haplotype analysis of the LDL receptor gene. Journal of Molecular Medicine. 69(18). 842–846. 3 indexed citations
15.
Rauh, G, H. Schuster, Joseph F. Fischer, et al.. (1991). Familial defective apolipoprotein B-100: Haplotype analysis of the arginine(3500) → glutamine mutation. Atherosclerosis. 88(2-3). 219–226. 35 indexed citations
16.
Rauh, G, H. Schuster, Barbara A. Miller, et al.. (1990). Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia. Atherosclerosis. 83(1). 81–87. 27 indexed citations
17.
Schuster, H., et al.. (1989). Four DNA polymorphisms in the LDL-receptor gene and their use in diagnosis of familial hypercholesterolemia. Human Genetics. 82(1). 69–72. 21 indexed citations
18.
Keller, C., et al.. (1987). Atherosclerosis of the carotid arteries documented by Duplex scan as a predictor of coronary artery disease in familial hyperlipidemias. Journal of Molecular Medicine. 65(1). 34–39. 13 indexed citations
19.
Keller, C., G. Wolfram, & N. Zöllner. (1976). [Treatment of hyperlipemia and hyperuricemia with 2-acetamidoethyl-(4-chlorophenyl)-(3-trifluoromethylphenoxy)-acetate (halofenate), a derivative of clofibrate].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 26(12). 2221–4. 1 indexed citations
20.
Zöllner, N., C. Keller, & G. Wolfram. (1976). [Treatment of hypercholesterolemia with beta-pyridylcarbinol. Experiences after long term treatment over 8 years (author's transl)].. PubMed. 71(18). 768–74. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026